Loading news article.

Newsbenzinga

QUICK SPARK: J&J Eyes Worst Day Since April 2025 with MedTech Miss

Oct 13, 2026, 14:23 ET · Published

Article summary

Johnson & Johnson beat third-quarter profit estimates and raised its 2026 forecast. After MedTech sales missed estimates, the stock still fell about 6%, its steepest one-day drop since April 1, 2025. XLV fell 1.1%.

An excerpt from the original article.

Related companies

JNJJNJView stock

Repost

Comments —

Loading comments…